Garetosmab    (DrugBank: Garetosmab)

1 disease
IDDisease name (Link within this page)Number of trials
272Fibrodysplasia ossificans progressiva1

272. Fibrodysplasia ossificans progressiva    [ 23 clinical trials,   21 drugs,   (DrugBank: 4 drugs),   10 drug target genes,   87 drug target pathways]
Searched query = "Fibrodysplasia ossificans progressiva", "FOP"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 23 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04577820
(ClinicalTrials.gov)
November 5, 202030/9/2020Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)Evaluation of Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans ProgressivaFibrodyplasia Ossificans Progressiva (FOP);Heterotopic Ossification (HO)Drug: garetosmabRegeneron PharmaceuticalsNULLNot yet recruiting18 Years60 YearsAll6Phase 3NULL